Global Medical Second Opinion Market expected to reach $20.45 billion by 2031, driven by increasing demand.

From GlobeNewswire: 2024-05-21 11:56:00

The global Medical Second Opinion Market is expected to grow from $7.12 billion in 2024 to $20.45 billion by 2031, with a CAGR of 16.3%. Increasing complexity of chronic diseases is driving demand for second opinions. Health insurance providers are promoting second medical opinions to reduce unnecessary interventions and healthcare costs.

Telemedicine and virtual platforms are becoming popular for seeking medical second opinions. AI and machine learning tools are being integrated to provide more accurate diagnoses and treatment plans. The cancer segment dominates the market, driven by the rising incidence of various cancers. Neurological disorders segment is expected to witness significant growth due to increasing cases of diseases like Alzheimer’s.

Physicians segment holds over 40% share in the global medical second opinion market in 2024, due to reliance on experienced opinions for critical illnesses. Hospitals segment is expected to grow steadily, with increasing partnerships with second opinion platform providers. North America is anticipated to lead the market, supported by advanced healthcare infrastructure and favorable reimbursement policies.

Key players include M|O|C Cancer Care & Research Centre, Yashoda Hospital, Mayo Clinic, Johns Hopkins Hospital, and UCLA Medical Center. Strategic collaborations and new service launches are key strategies being adopted. The global market size is valued at $7.12 billion in 2024, with a CAGR of 16.3% expected during 2024-2031. The cancer segment is set to dominate, driven by the rising burden of cancer globally.



Read more at GlobeNewswire: Medical Second Opinion Market Size to Worth USD 20.45 Bn By